CRVS Corvus Pharmaceuticals, Inc.

Healthcare

$12.84+0.00%OpenMarket Cap: $1.08B

As of 2026-05-26

Analyst Consensus

Consensus

Buy

Target (Consensus)

$33.17

Target (Median)

$31.00

Target Range

$27.00 - $42.00

Upside from current price: 158.3%

1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-13	Oppenheimer	maintain	Outperform	Outperform
2026-01-22	Jefferies	maintain	Buy	Buy
2026-01-21	Barclays	maintain	Overweight	Overweight
2026-01-21	Oppenheimer	maintain	Outperform	Outperform
2026-01-20	HC Wainwright & Co.	maintain	Buy	Buy

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.85	$4.5M	4
Sun Dec 31	$-0.75	$31.8M	6
Mon Dec 31	$-0.42	$83.9M	4
Tue Dec 31	$0.18	$159.3M	2